hotspot -WSS

hotspot

author：fashion 2025-09-30 20:18:09 - browse：6522

LONDON — Seeking to build up its pharma business, the Japanese conglomerate Asahi Kasei is moving to buy Swedish biotech Calliditas Therapeutics in a nearly $1.1 billion cash deal, the companies said Tuesday.

The firm’s offer of $19.68 per share amounts to an 83% premium versus Calliditas’ closing price on a Swedish exchange Monday. The Calliditas board has unanimously recommended that shareholders accept the offer, the company said, adding that it “aims to realize the benefits of being part of a larger platform” by being acquired.

Calliditas has an approved drug on the U.S. market called Tarpeyo, which treats a kidney disease called IgA nephropathy. The condition has in recent years attracted interest from a number of pharma companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Roche drug slashes death risk in early

WSS

Paxlovid should be available without a positive Covid test

After a drawn out lobbying fight, ARPA

Study on Amgen’s bispecific immunotherapy produces positive data

Would Medicare drug price negotiations stall in a shutdown?

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Paxlovid should be available without a positive Covid test

knowledge

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

How one medical school became remarkably diverse

Did you have Obamacare on your GOP debate bingo card?

Apple is now the first public company to be valued at $3 trillion

How AI can help patients find reliable information about doctors

Hollywood unions extend contract negotiations for actors

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Sports medicine is finally prioritizing gender equality

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Peter Hotez and the public health issue of online harassment

一是，加大各级财政补助力度。

Wikipedia

Would Medicare drug price negotiations stall in a shutdown?

STAT Readout Newsletter: Biotech news today

Listen: Who gets the credit for GLP

Why do women spend more than men on medical expenses?

FDA clears Verve to begin U.S. study of gene

Smaller biotechs seek to piggyback on weight loss drug boom

leisure time

Wikipedia

entertainment

hotspot